Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Swine-origin A/H1N1 Influenza”

30 trials

Showing 20 of 30 results

Testing effectiveness (Phase 2)Study completedNCT00953524
What this trial is testing

Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 849
Post-approval studies (Phase 4)Study completedNCT01079273
What this trial is testing

Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects

Who this might be right for
Influenza
Opera CRO, a TIGERMED Group Company 7
Not applicableStudy completedNCT01037855
What this trial is testing

Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine

Who this might be right for
Novel Influenza A (H1N1)A New Flu Virus of Swine Origin
Novartis Vaccines 4,028
Early research (Phase 1)Study completedNCT01855945
What this trial is testing

Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.

Who this might be right for
Prophylaxis of A/H3N2v Influenza
Novartis Vaccines 627
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Large-scale testing (Phase 3)Study completedNCT00973349
What this trial is testing

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults

Who this might be right for
Influenza
Novartis 2,719
Testing effectiveness (Phase 2)Study completedNCT00956046
What this trial is testing

Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 401
Not applicableStudy completedNCT01032980
What this trial is testing

Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults

Who this might be right for
InfluenzaSwine-Origin A/H1N1 Influenza Virus
Sanofi Pasteur, a Sanofi Company 3,934
Testing effectiveness (Phase 2)Study completedNCT00992212
What this trial is testing

Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10

Who this might be right for
Pandemic Influenza Disease
Novartis Vaccines 418
Large-scale testing (Phase 3)Study completedNCT00970177
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 812
Large-scale testing (Phase 3)Study completedNCT00996138
What this trial is testing

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects

Who this might be right for
Influenza
Novartis Vaccines 200
Large-scale testing (Phase 3)UnknownNCT01040078
What this trial is testing

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Centers for Disease Control and Prevention, China 900
Large-scale testing (Phase 3)Study completedNCT01053143
What this trial is testing

Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India

Who this might be right for
InfluenzaPandemic InfluenzaInfluenza A Virus, H1N1 Subtype
Sanofi Pasteur, a Sanofi Company 100
Testing effectiveness (Phase 2)Study completedNCT00992836
What this trial is testing

Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

Who this might be right for
HIV InfectionsH1N1 Influenza Virus
National Institute of Allergy and Infectious Diseases (NIAID) 155
Testing effectiveness (Phase 2)Study completedNCT00952419
What this trial is testing

Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 474
Post-approval studies (Phase 4)Study completedNCT01069367
What this trial is testing

Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 100
Testing effectiveness (Phase 2)Study completedNCT00954798
What this trial is testing

Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 450
Large-scale testing (Phase 3)Study completedNCT00972816
What this trial is testing

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)

Who this might be right for
Influenza
Novartis Vaccines 1,357
Testing effectiveness (Phase 2)Study completedNCT00952276
What this trial is testing

Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi 548
Testing effectiveness (Phase 2)Study completedNCT01089660
What this trial is testing

The Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 202
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation